dalteparin has been researched along with Adenocarcinoma of Lung in 5 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Adenocarcinoma of Lung: A carcinoma originating in the lung and the most common lung cancer type in never-smokers. Malignant cells exhibit distinct features such as glandular epithelial, or tubular morphology. Mutations in KRAS, EGFR, BRAF, and ERBB2 genes are associated with this cancer.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhong, GX | 1 |
| Gong, Y | 1 |
| Yu, CJ | 1 |
| Wu, SF | 1 |
| Ma, QP | 1 |
| Wang, Y | 1 |
| Ren, J | 1 |
| Zhang, XC | 1 |
| Yang, WH | 1 |
| Zhu, W | 1 |
| Zhuang, X | 1 |
| Qiao, T | 1 |
| Xu, G | 1 |
| Yuan, S | 1 |
| Zhang, Q | 1 |
| Chen, X | 1 |
| Alturkistani, A | 1 |
| Ghonem, N | 1 |
| Power-Charnitsky, VA | 1 |
| Pino-Figueroa, A | 1 |
| Migliore, MM | 1 |
| Papageorgiou, C | 1 |
| Vandreden, P | 1 |
| Marret, E | 1 |
| Bonnet, F | 1 |
| Robert, F | 1 |
| Spyropoulos, A | 1 |
| Galea, V | 1 |
| Elalamy, I | 1 |
| Hatmi, M | 1 |
| Gerotziafas, GT | 1 |
| Mitma, AA | 1 |
| Varghese, JG | 1 |
| Witt, D | 1 |
| Zarich, SW | 1 |
5 other studies available for dalteparin and Adenocarcinoma of Lung
| Article | Year |
|---|---|
Significantly inhibitory effects of low molecular weight heparin (Fraxiparine) on the motility of lung cancer cells and its related mechanism.
Topics: Actin Cytoskeleton; Adenocarcinoma; Adenocarcinoma of Lung; Animals; Cell Adhesion; Cell Movement; C | 2015 |
Combination of nadroparin with radiotherapy results in powerful synergistic antitumor effects in lung adenocarcinoma A549 cells.
Topics: A549 Cells; Adenocarcinoma; Adenocarcinoma of Lung; Apoptosis; Basigin; Cell Movement; Cell Prolifer | 2016 |
Inhibition of PAR-1 Receptor Signaling by Enoxaparin Reduces Cell Proliferation and Migration in A549 Cells.
Topics: A549 Cells; Adenocarcinoma of Lung; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung | 2019 |
Lobectomy and postoperative thromboprophylaxis with enoxaparin improve blood hypercoagulability in patients with localized primary lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Anticoagulants; Blood Coagulation; Blood Coagulation T | 2013 |
Stroke and a valvular lesion in a patient with stage IV non-small cell lung cancer.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Anticoagulants; Cerebellum; Diagnosis, Differential; E | 2016 |